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Background: In order to study the biosynthesis of vitamin B,,, it is necessary 
to produce various intermediates along the biosynthetic pathway by enzymic 
methods. Recently, information on the organisation of the biosynthetic pathway 
has permitted the selection of the set of enzymes needed to biosynthesise any 
specific identified intermediate. The aim of the present work was to use 
recombinant enzymes in reconstituted multi-enzyme systems to biosynthesise 
particular intermediates. 
Results: The products of the cobG and CON genes from Pseudomonas 
denitrificans were expressed heterologously in Escherichia coli to afford good 
levels of activity of the corresponding enzymes, CobG and CobJ. Aerobic 
incubation of precorrin-3A with the CobG enzyme alone yielded precorrin3B. 
When CobJ and S-adenosyl-L-methionine were included in the incubation, the 
product was precorrin-4. Both precorrin-3B and precorrin-4 are known 
precursors of vitamin B, 2 and their availability has allowed new mechanistic 
studies of enzymic transformations. 
Conclusions: Our results show that the expression of the CobG and CobJ 
enzymes has been successful, thus facilitating the biosynthesis of two 
precursors of vitamin B,,. This lays the foundation for the structure 
determination of CobG and CobJ as well as future enzymic experiments 
focusing on later steps of vitamin B,, biosynthesis. 
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Introduction 
Enzymic synthesis of biosynthetic intermediates has been 
routinely employed in collaborative research on the 
biosynthesis of vitamin B,, (Figure la; 9) carried out in 
Paris and Cambridge [l,Z] and also in Texas [3]. The 
enzymes used for much of the European work were con- 
tained in cell-free systems prepared from strains of 
Pseudomonas denitrijkans carrying all eight genes (or 
various subsets of these genes) necessary for the biosyn- 
thesis of hydrogenobyrinic acid (Figure la; 8) from precor- 
rin-‘2 (Figure la; 3) [4]. In addition, many of the more 
recent experiments in our laboratory have been based on 
the use of recombinant enzymes in reconstituted multi- 
enzyme systems [5,6] and have led to further important 
discoveries about the biosynthetic pathway. 
The work presented here depended on five recombinant 
enzymes produced by expression of their corresponding 
genes in an Eschetichia coli host. Three enzymes encoded by 
the hemB, 4emC and AemD genes were porphobilinogen syn- 
thase (PBG synthase; EC 4.2.1.24), hydroxymethylbilane 
synthase (HMB synthase; EC 4.3.1.8) and uroporphyrino- 
gen III synthase (uro’gen III synthase; EC 4.2.1.75), respec- 
tively. The genes have been identified and characterised 
from several organisms, but those from Bacihs subG.s [7] 
were preferred for expression in E. colz [6]. The use of the 
B. su&&s genes had the great advantage that the uro’gen 
III synthase produced was stable, unlike the enzyme from 
other sources [8]. The remaining two enzymes encoded by 
the cobA and cob1 genes were from P. denitrzjkans - 
S-adenosyl-L-methionine: uroporphyrinogen III methyl- 
transferase (SUMT) [9] and S-adenosyl-L-methionine : 
precorrin-2 methyltransferase (SP,MT) [lo], respectively. 
Their expression in E. coli has been described [6]. 
These enzyme preparations from B. subtihs and P. denhii- 
cans converted 5aminolaevulinic acid (ALA, Figure la; 1) 
preparatively and in high yield into three of the early inter- 
mediates involved in the biosynthesis of vitamin Bra: 
uro’gen III (Figure la; Z), precorrin-2 (Figure la; 3) and 
precorrin-3A (Figure la; 4). Using this method, the enzymic 
synthesis of nonlabelled [ 11,l Z] and specifically labelled 
[ 13-171 forms of 2, 3 and 4 has proved invaluable for inves- 
tigating the biosynthetic pathway of vitamin B,,. Enzymic 
syntheses have also been used by other groups for various 
types of natural products including tetrapyrroles [18]. 
We wanted to use the same approach with recombinant 
enzymes to advance further along the biosynthetic path- 
way because this method has the advantage of allowing 
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Some early biosynthetic intermediates on the 
pathway to vitamin B,,. (a) The biosynthesis 
of precorrin3B (5) and precorrin-4 (6) on the 
pathway to vitamin B,, (9). An intermediate is 
called a ‘precorrin’ if it precedes the formation 
of the corrin ring present in 8. The number 
after ‘precorrin’ gives the number of methyl 
groups that have been introduced from 
S-adenosyk-methionine to form that 
substance during the steps going forward 
from uro’gen Ill (2). When this number is the 
same for two or more intermediates, they are 
distinguished by an added letter. Genes and 
gene products: hemB, PBG synthase CALA 
dehydratase); hemC, HMB synthase (=PBG 
deaminase); hemD, uro’gen III synthase 
(zcosynthetase); cobA, S-adenosyk-methio- 
nine : uroporphyrinogen Ill methyltransferase 
(=SUMT); cob/, S-adenosyl-L-methionine : 
precorrin-2 methyltransferase (=SP’LMT); 
cobG, CobG; cobJ, CobJ. (b) Derivatives of 
precorrin3A (4) and precorrin-4 (6). 
TMIBC: trimethylisobacteriochlorin. 
experiments on a specific enzymic transformation, or a This paper describes the expression of the cobG and cobJ 
selected series of such steps, without interference from genes from P. denitn$cans in an E. COL host and the use of 
competing enzymic reactions. Having a full knowledge of their respective gene products in a coupled-enzyme syn- 
the biosynthetic organisation of the pathway to vitamin thesis of the tetramethylated intermediate for vitamin B,,, 
B,, [l], we focused on the two enzymes following SP,MT precorrin-4 (Figure la; 6). Precorrin-4 was first detected 
encoded by the genes cobG and cobJ. by the group in Paris and was isolated as its didehydro 
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derivative, factor IV [19]. The structures shown for precor- 
rin-4 and factor IV (Figure lb; 6a) were established using 
‘SC-labelling and nuclear magnetic resonance (NMR) 
spectroscopic analysis 114,191. The factor IV enzymically 
synthesised in the present work was isolated chromato- 
graphically or as its octamethyl ester (Figure lb; 66). 
Results and discussion 
Expression of cobG and cobl 
The strategy employed for the expression of the cobG gene 
from P. denitrificns in E. coli required site-directed muta- 
genesis to engineer an N&I restriction endonuclease site 
over the ATG start codon of the gene (see the Materials 
and methods section, Construction of pSD37). Using this 
newly constructed N&I restriction site, the mutated cobG 
gene was cloned downstream of the strong E. co/i Pt7p pro- 
moter and the efficient ribosome-binding site from the h 
611 gene to form a convenient cassette for further cloning. 
In contrast, expression of the cobJ gene of P. u’enitrjificans in 
E. coli was achieved by simply cloning an appropriate P. 
denitrijicans chromosomal fragment from pXL330 down- 
stream of the tandem thermoinducible bacteriophage h 
promoters in pCE30. 
Expression of the cobG and cobJ genes in these heterolo- 
gous systems led to the accumulation of proteins with 
M,=46,000 and M,= 27,000, respectively, as measured by 
sodium dodecyl sulphate polyacrylamide gel electrophore- 
sis analysis of cell-free extracts. The relative molecular 
masses of these accumulated proteins agree with the 
reported M, for the CobG and CobJ enzymes purified 
from P. denitrificans [ZO] and with the predicted subunit 
M, calculated from the amino acid sequence derived from 
the DNA sequence of the cobG and cobJ genes [4]. 
The CobG enzyme is known to catalyse the oxidative con- 
version of precorrin-3A into precorrin-3B (Figure la; 5) 
[Zl], a step which requires oxygen [ZZ]. In addition, CobJ 
has been shown to carry out the subsequent conversion of 
precorrin-3B into precorrin4, a process which involves 
both ring contraction and methylation at Cl7 [19]. In 
order to assess the two enzyme preparations from the 
present work, we first tested the ability of the CobG 
enzyme to catalyse the conversion of precorrin-3A into 
precorrin-3B. Surprisingly, the initial preparations of 
CobG failed to do so. But, because CobG is an 
iron-sulphur protein [ZO], freshly prepared ferric chloride 
was added to the fermentations of the engineered E. coli 
strain. This change, together with a reduction in the aera- 
tion of the incubation, afforded cells yielding CobG 
enzyme which readily converted precorrin-3A into precor- 
rin-3B. The latter is easily oxidised during handling to its 
didehydro derivative, factor IIIB [ZO] which was isolated 
by high performance liquid chromatography (HPLC) and 
identified by electrospray mass spectrometry. No further 
work was done on the synthesis of precorrin-3B because, 
having established that active CobG enzyme had been 
produced, our aim was to use the CobG and CobJ 
enzymes together to synthesise precorrin-4. The heterolo- 
gous expression of the P. denitrzjicans cobG gene has also 
been briefly reported by the group in Texas [ZZ]. 
Preparation of precorrin-4 and factor IV 
In order to provide pure substrate, the precorrin-3A pre- 
pared by our coupled-enzyme system [6] was isolated and 
purified as the ester of its didehydro derivative, the tri- 
methylisobacteriochlorin (TMIBC; Figure lb; 4a). Reduc- 
tion was therefore necessary to return to precorrin-3A (the 
natural substrate for the CobG enzyme). Material pro- 
duced by controlled catalytic hydrogenation of the ester 
4b (Figure lb) followed by hydrolysis of the ester groups 
was successfully converted into precorrin4 by the CobG 
and CobJ coupled-enzyme system in yields similar to 
those obtained in the method based on enzymic reduction 
(see below). This demonstrates unambiguously that both 
overproduced proteins are enzymically active. An experi- 
mentally simpler approach involved enzymic reduction of 
TMIBC, again prepared by hydrolysis of its ester, by the 
reductase present in cell-free extracts of P. a’eh$cans 
[23]. This simply involved addition of the cell-free extract 
and NADH to our engineered preparation of the CobG 
and CobJ enzymes containing TMIBC. 
The amount of reductase to be added was studied with 
the aim of providing the optimum supply of precorrin-3A 
for the coupled-enzyme system. Interestingly, doubling 
the amount of reductase added either had little effect on 
the overall yield of precorrin-4 (measured as factor IV) or 
could even reduce it. It should be noted that the strain of 
P. a’enitrificans used as the source of the reductase does 
not express the cobM gene; this avoids conversion of the 
biosynthesised precorrin-4 into precorrin-5. 
The optimum time for the incubation was 5-9 h (similar to 
that found by the group in Paris) [ZO]; the decreased yields 
observed after 9 h probably resulted from the decompo- 
sition of the labile precorrin4, which outweighed its 
further production. By using an incubation period of 5 h, 
the maximum yield of precorrin-4 was obtained with 
maximal recovery of unused substrate. 
In order to allow many small-scale yet accurate experi- 
ments on the production of factor IV, i4C-labelling was 
used. The substrate, [2,7,20-met~yl-14C]precorrin-3A was 
prepared as reported [6], but using [methyl-i4C]S-adenosyl- 
L-methionine rather than unlabelled material. The molar 
specific activity of the resultant labelled TMIBC, and 
therefore of the [2,7,20-me~~yl-i4C]precorrin-3A prepared 
from it, was determined. The yield of factor IV could then 
be calculated from the total 14C activity it carried. The 
best yields were 19-21% under the conditions outlined 
above, with -15% of substrate recovered together with 
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11% of the corresponding monolactone. Oxidative lactoni- 
sation occurs readily when TMIBC is handled in the pres- 
ence of oxygen [24]. This r4C experiment also allowed the 
extinction coefficient for factor IV to be determined in 
water containing 0.1% trifluoroacetic acid: E= 3.8 x lo4 at 
the Lax of 370 nm. 
Esterification of factor IV 
The octamethyl ester derivative of factor IV was prepared 
using diazomethane. The molecular formula of the product 
was shown to be correct (C,,H,,N,O,,) by accurate mass 
spectrometry measurement. A second product was also 
formed in this esterification step having a molecular 
formula C53H69N4017 (by mass spectrometry measure- 
ment), corresponding to a nonamethyl derivative of factor 
IV. When the treatment with diazomethane was stopped 
after 15s, only a small amount of C,,H,,N,O,, was 
formed so the required octamethyl ester (C,,H,,N,O,,) 
was obtained in >75% yield. Longer times gave greater 
proportions of the nonamethyl product and for times 
> 1 min, general decomposition set in. This unwanted nona- 
methyl material was not further examined but it was presu- 
mably the octamethyl ester of an N-methylated derivative, 
for example 6e (Figure lb); a mixture of N-methylated tau- 
tomeric forms of factor IV ester cannot, however, be 
excluded. 
Significance 
Recent developments have made it clear that the most 
powerful way to solve a complex biosynthetic problem is 
to identify the set of enzymes involved and then to use 
the strengths of analytical and organic chemistry to 
work out which step each enzyme catalyses and the 
structure of its product. The first of these stages is based 
on genetics and molecular biology. The elucidation of 
the complete biosynthetic pathway to vitamin B,, [ 11 is a 
dramatic example of how successful this approach can 
be. Knowledge of the functions of the various enzymes 
and of their sequence of action opens the way to heterol- 
ogous expression of any of the component enzymes. 
With substantial quantities of protein thus available, 
there is the opportunity to biosynthesise the intermediate 
of interest in sufficient quantities, for example, for study 
by 13C-nuclear magnetic resonance. 
The work described here shows that two enzymes of the 
B,, biosynthetic pathway in Pseudomonas denitrificans 
which are particularly interesting have been successfully 
produced by heterologous expression of their genes in 
Escherichia coli. One is CobG, an iron-sulphur protein 
that carries out an oxidative transformation, and the 
other is CobJ, which catalyses a conversion involving 
both ring contraction and C-methylation. This lays the 
foundation for further advances, an important target 
being the crystallisation of these proteins for X-ray 
structure determination. 
In addition, the CobG and CobJ enzymes have been 
applied in combination with those encoded by the hemB, 
hemC, hemD, cobA and cobl genes to allow the enzymic 
synthesis of precorrin-4 and factor IV from S-aminolae- 
vulinic acid and S-adenosyl-L-methionine. This provides 
a convenient source of precorrin-4 as a substrate for 
future enzymic experiments focusing on the later steps 
of vitamin B,, biosynthesis. 
Materials and methods 
Genera/ details 
Electronic spectra were recorded on a Cecil CE 5501 ultra-violet (UV) 
spectrophotometer. Electrospray mass spectrometry was performed on 
a VG quadrupole mass spectrometer using VG Lab Base software (VG 
Analytical). ‘H-NMR spectra were recorded on a Bruker WH-400 instru- 
ment operating at 400 MHz and the solvent signal was used as internal 
reference. HPLC purifications were carried out using a Waters 600E 
multisolvent delivery system and pigments were detected by a Cecil CE 
272 UV spectrophotometer equipped with a Venture RE 511.20 
recorder. The reverse-phase column was a PhaseSep Nucleosil 50DS 
and, before injection, samples were filtered through Acrodisc 3 
(0.45 mm, Gelman Sciences). Radiochemical analyses were carried out 
on a United Technologies Packard 2000 CA Tricarb liquid scintillation 
analyser. Centrifugations were performed on an Europa 24M centrifuge 
and large scale fermentations, unless otherwise stated, were performed 
in a Microferm fermenter (New Brunswick Scientific) with constant stir- 
ring (200 rpm) and an air flow (4 I mint) using a Radiometer type TTT2 
auto-titrator for pH control. All solvents were dried prior to use and 
water used throughout was distilled and further purified with a MilliQ 
system (Millipore). Solvents were evaporated on a Biichi Rotavapor at 
reduced pressure. 
Bacterial strains and DNA 
Bacterial strains and plasmid DNAs are listed in Table 1. E. co/i AN1 459 
(i/v fhr supf recA sr/;:Tn 70) 1251 and MC1 060 (A(/ac/POZYA)X74 ga/lJ 
ga/K strA2 hsdR) [26] and P. denitrificans G3575 (Rif’ A(cobF to 
coblLn)) [20] were used as hosts for all plasmids. E. co/i TGl (A(/acpro) 
thi supf hsdD8F’ proA /ac/~ZAM75) [27] was used as the recipient 
host for all Ml 3 derivatives. Bacteria were grown at 37’C in LB broth or 
on plates. For E. co/i strain AN1 459, cultures were grown at 30°C and 
media were supplemented with thymine (25 pg ml-l). Antibiotic supple- 
ments where used were ampicillin (5Opg ml-t) and chloramphenicol 
(20ugml-t). Plasmids pCE30 [28], pXL1283 [6], pXL330 [29] and 
pXL229 [20] and bacteriophage Ml 3tg131 [30] were as described. 
Oligonucleotides were synthesised on an Applied Biosystems oligonu- 
cleotide synthesiser and oligonucleotide-directed mutagenesis was per- 
formed using the system of Amersham. All other procedures used for 
DNA manipulations were essentially as described [31]. 
Reagents, chromatographic resins and enzymes 
Enzymes used for DNA manipulations were obtained from Stratagene, 
Pharmacia or Boehringer-Mannheim and were used in buffers recom- 
mended by the suppliers. Reagents and buffer components, lysozyme, 
antibiotics and S-adenosyl-L-methionine were from Sigma and LiChro- 
prep C-l 8 resin was from Merck. Radioactive [i4C-methyl]S-adenosyl- 
L-methionine (53 mCi mmol-I) was from Amersham and culture media 
from Difco. 
Plasmid constructions 
Construction of pSD37. The P. denitrificans cobG gene was expressed 
in f. co/i following the cloning of the cobG gene downstream of the trp 
promoter in a derivative of the pBR322-derived expression vector 
pXL694. Initially a 2.2 kb Bgill/Sphl fragment from pXL330 [291, carry- 
ing the entire cobG gene, was subcloned into the BamHl and Sphl sites 
of Ml 3tgl31 1301 leading to pXL1365. Oligonucleotide site-directed 
mutagenesis [32] was then performed on single-stranded pXL1365 
Research Paper Multi-enzyme synthesis of vitamin B,, biosynthetic intermediates Stamford et al. 449 
Table 1 
Bacterial strains and plasmid DNAs. 
Bacterial strain 
or plasmid 
Marker and 
replicon 
Relevant properties Reference 
or source 
P. denifrificans 
G3575 
E. coli 
AN1 459 
MC1 060 
TGI 
Plasmids 
M13tg131 
pCE30 
pXL330 
pXL1283 
pXL229 
pXL1365 
pXLl404 
pSD37 
pSD38 
Rif’ 
fl Ml 3 bacteriophage derivative [301 
Amp’ ColEl Carries bacteriophage k promoters and cl857 allele 1281 
Amp’ ColEl 8.7 kb EcoRl (cobF to cob/W) fragment from pXLl51 cloned into pUC13 [291 
Amp’ ColEl 1.3 kb pXL1262 NdellSsd (cobA) fragment cloned into pXL694 P31 
Km’ RSFl 010 3.3 kb EcoRIIBamHI (cobH to cobK) fragment from pXL152 [201 
fl 2.2 kb pXL330 BgllllSphl (cobG) fragment cloned into the BamHl and Sphl sites of M13tgl31 This study 
fl Site-directed mutant derivative of pXL1365 with an Ndel site insertion This study 
Amp’ ColEl 1.9 kb pXLl404 NdellSphl (cobG) equivalent fragment cloned into pXL1283 This study 
Amp’ ColEl 4.3 kb pXL330 Smal (cobH to cobK) fragment cloned into pCE30 This study 
Rif’ strain SC51 0 A(cobF to cob/W), produces no cobalamin Dl 
i/v thr supE recA srl::Tn 10 
A(laclPOZYA)X74 gallJ galK strA2 hsdR 
A(/acpro) thi supE hsdD5lF’ proAB laclqZAM15 
[251 
I261 
1271 
using oligonucleotide 546 5’CATCAAATCCGTCATATGTTGAGGTT- 
CTCC 3’) to construct the mutagenised plasmid pXLl404 which has a 
Ndel restriction endonuclease site (bold) over the translation initiation 
signal (italicised) in the cobG gene sequence 5’GGAGAACCTCAA- 
GTGATGACGGATTTGATG 3’. A 1.9 kb Ndel/ Sphl fragment contain- 
ing the entire cobG gene equivalent to that in pXL1404 was then 
subcloned into pXLl283 [61 to give pSD37. 
Construction of pSD38. The P. denitrificans cobJ gene was expressed 
in E. co/i following the cloning of the cobJ gene downstream of the 
bacteriophage tandem h P, and P, promoters in the vector pCE30 
[28]. Plasmid pSD38 (8.3 kb) was constructed by ligation of the 4.3 kb 
Smal fragment containing the P. denitrificans cobJ gene from pXL330 
[29] into the Smal site of pCE30. 
Protein chemistry 
Expression of the CobJ enzyme. E. coliAN1459lpSD38 was grown at 
30°C in LB broth (1 I) supplemented with ampicillin (50pgml-‘) and 
thymine (25pgml-1) to D,,, -0.6. After rapid temperature shift to 
42”C, growth was continued at 42°C for 4 h. The culture was chilled 
and cells were harvested and lysed as described. 
Expression of the CobG enzyme. E. coli MCl060IpSD37 was grown 
at 37’C in MS medium (50ml) supplemented with ampicillin 
(lOO~gml-I), casamino acids (4% w/v final) and tryptophan 
(100 I-19 ml-‘) in a baffled flask for 16 h. This culture was then used to 
inoculate 1 I of the same medium with 10 ,uM FeCI, but without trypto- 
phan supplement. Growth was continued at 37°C in a non-baffled 
conical flask for a further 18 h. The culture was chilled and cells were 
harvested and lysed as described. 
Lysis of cells. Buffers for cell lysis were thoroughly deoxygenated 
under argon prior to use and all procedures during enzyme prepara- 
tions were at 0-5°C. Chilled cell cultures were harvested (12,OOOxg, 
15 min), resuspended to a density where Dsg5 -200 with 100 mM Tris 
HCI (pH 7.6), 10% (w/v) sucrose, poured into liquid N, and stored at 
-70°C. Cells were thawed and diluted to D,,, - 100 to the final com- 
position of lysis buffer (100 mM Tris HCI (pH 7.6), 10% (w/v) sucrose, 
100 mM NaCI, 5 mM dithiothreitol, 20 mM spermidine HCI, 0.1% (v/v) 
Brij-58). Lysozyme (0.2 hg ml-l) was added and the mixture was stirred 
for 2 h at 0%. Cell-free extracts were then prepared by centrifugation 
(4O,OOOxg, 30min) and the supernatant obtained was dropped into 
liquid N, and stored at -70°C. 
Preparafion of TMIBC f4a) and precorrin-3A (4) 
TMIBC was used as starting material for all enzymic experiments and 
was biosynthesised essentially as described [61. This material was 
reduced enzymically to precorrin-3A in the incubation being run, as illus- 
trated in the next section. Alternatively, catalytic hydrogenation of its 
octamethyl ester 4b under conditions kindly provided by A. Eschen- 
moser (ETH, Ztirich, Switzerland) afforded precorrin-3A octamethyl ester 
which was then hydrolysed before incubation. TMIBC octamethyl ester 
(2OOkg; 4b) in methyl acetate (1.5 ml) was stirred at room temperature 
under hydrogen for 0.5 h with platinum on activated carbon (5%; 2 mg) 
and the subsequent steps were carried out in a glove box (~5 ppm 0,). 
The catalyst was removed by filtration through a small Celite column and 
the filtrate evaporated. The yellow residue was dissolved in 2 M aqueous 
piperidine (200 ~1) and stirred at room temperature for 48 h to afford 
precorrin-3A ready for enzymic incubations. To provide TMIBC for incu- 
bations in which it was enzymically reduced in situ, TMIBC octamethyl 
ester was first hydrolysed in 2 M aqueous piperidine as above. 
Preparation of precorrin-4 (6) and facfor IV (6a) 
The final concentration of reagents in the buffer for enzymic incubations 
was 1 OOmM Tris Cl (pH 7.6), 5% (w/v) sucrose, 50mM NaCI, 2.5mM 
DTT, 0.6 mM S-adenosyl-L-methionine and 1.2 mM NADH. Buffers for 
incubations were thoroughly deoxygenated under argon prior to use 
and all the steps for preparation of incubation mixtures containing the 
enzymes were at 0-5’C. The volumes of enzyme solution used during 
the following incubations are related back to the volumes produced 
from known concentrations of suspended cells (see Lysis of cells). In 
this way, the directions hold good for any amount of cells used at the 
outset. The enzymic extracts obtained from E. co/i AN1 459 I pSD38 (1 
part) and E. co/i MCl060/pSD37 (1 part) were thawed on ice and 
diluted twofold to the final concentration of incubation buffer containing 
precorrin-3A or TMIBC (5pg ml-‘). When the substrate was TMIBC, a 
cell-free extract of G3575IpXL229 [201 was added to provide the 
reductase enzyme [231 which regenerates precorrin-3A. The mixture 
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was divided into volumes of 12ml in conical screw cap tubes 
(17 mmx 120mm) and incubated still and horizontally at 30°C in a con- 
stant temperature oven in the dark for 5 h. The tubes were not flushed 
with argon prior to sealing with the screw cap which ensured that air 
comprised -20% of the total volume in each incubation vessel. The 
mixture was then cooled on ice, acidified with 2N HCI to pH4.0, 
flushed with argon and the precipitated protein was removed by cen- 
trifugation (4O,OOOxg, 1 Omin, 4’C). The supernatant was passed 
through a LiChroprep column (2.0x0.5cm) which had been previously 
washed with methanol and then water. The column was washed with 
water and pigments were eluted with 50% acetonitrile in water ready 
for separation by HPLC (PhaseSep Nucleosil 50DS) using a gradient of 
1% to 25% acetonitrile in aqueous KH,PO,/ K,HPO, buffer (100 mM, 
pH 7.0) at a flow rate of 1 ml mini. Fractions containing factor IV were 
detected by UV (370nm) using an authentic sample [14] as standard; 
yield 20%. TMIBC (15%) was also recovered together with its mono- 
lactone (11 O/o). The enzymically synthesised factor IV was shown to be 
identical with the standard sample by chromatography, by UV-visible 
absorption and also by mass spectrometry on its octamethyl ester. 
Esterification of factor IV (6a) 
The foregoing solution of factor IV was concentrated by adsorption 
onto a LiChroprep column and elution with the minimum volume of 
50% aqueous acetonitrile as before. Methanol (1 ml) was added to the 
eluant (1 ml) and an ethereal solution of diazomethane was added 
dropwise but quickly to the stirred solution until a slight excess per- 
sisted. After 15s the organic solvents were evaporated and the 
aqueous solution was lyophilised to afford factor IV octamethyl ester as 
a blue amorphous residue. For unlabelled factor IV octamethyl ester 6b 
by electrospray mass spectroscopy MH+ 1019.4538; C,,H,,N,O,, 
requires I1/I+H 1019.4501. When the treatment with diazomethane 
was extended beyond 15 s, a peak for a second product appeared in 
the mass spectrum at n/lH+ 1033.4748. This indicates that this material 
is a nonamethyl derivative of factor IV (C,,H,,N,O,, requires I1/I+H 
1033.4657; see the Results and discussion section). 
14C-labelling experiments on factor IV 
[2,7,20-methyl-14ClTMlBC were prepared as described for unlabelled 
material [61 on a scale such that the volume of buffer solution contain- 
ing all the enzymes was 100 ml. To this was added ALA (11 mg), then 
[i4C-methy/JS-adenosyl-L-methionine (200 pl at 25 uCi ml-l in aqueous 
sulphuric acid). After a few minutes, unlabelled S-adenosyl-L-methion- 
ine (14 mg) was added and the incubation was continued and worked 
up as described [6] to yield [2,7,20-mefhyl-14C]TMlBC octamethyl ester 
(777 ug), specific activity 4.25x 1 O6 dpm pmol-I. This product was 
diluted with unlabelled TMIBC ester to give material of specific activity 
4.36 x 1 O5 dpm pmol-l which was hydrolysed as usual and the resultant 
TMIBC was enzymically converted into factor IV as described above. 
The total activity of this product then allowed calculation of its yield. 
From the accurate quantity of factor IV so measured, its molar extinc- 
tion coefficient at 370 nm, the strongest absorption in water containing 
1% trifluoroacetic acid, was determined as 3.79x 104M-1 cm-t. 
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